John Laurence Kulp Iii
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$5.7MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $5.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 23, 2026 | NIH | SBIR Phase II An Open Web Service For Fragment-based Design of Small Molecule Inhibitors | $1.0M | CONIFER POINT PHARMACEUTICALS, LLC |
| Jun 3, 2025 | NIH | SBIR Phase II An Open Web Service For Fragment-based Design of Small Molecule Inhibitors | $1.1M | CONIFER POINT PHARMACEUTICALS, LLC |
| Aug 19, 2024 | NIH | SBIR Phase II A Web Service for Fragment-based Selectivity Analysis of Drug Leads | $501K | CONIFER POINT PHARMACEUTICALS, LLC |
| Sep 11, 2023 | NIH | SBIR Phase II A Web Service for Fragment-based Selectivity Analysis of Drug Leads | $966K | CONIFER POINT PHARMACEUTICALS, LLC |
| Sep 9, 2022 | NIH | SBIR Phase II A Web Service for Fragment-based Selectivity Analysis of Drug Leads | $1.0M | CONIFER POINT PHARMACEUTICALS, LLC |
| Jul 7, 2020 | NIH | SBIR Phase I A Web Service for Fragment-based Selectivity Analysis of Drug Leads | $225K | CONIFER POINT PHARMACEUTICALS, LLC |
| Jan 22, 2020 | NIH | SBIR Phase I A Web Service for Fragment-based Selectivity Analysis of Drug Leads | $235K | CONIFER POINT PHARMACEUTICALS, LLC |
| Feb 18, 2019 | NIH | SBIR Phase II An Open Web Service For Fragment-based Design of Small Molecule Inhibitors | $750K | CONIFER POINT PHARMACEUTICALS, LLC |
Peer ranks
Federal funding#209
Awards as PI#190
Patents#273
Companies
- CONIFER POINT PHARMACEUTICALS, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.